Press release
Skin Cancer Market Growing Rapidly Huge Growth by 2031- Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc.
Skin Cancer Market is expected to grow at a CAGR 8% during the forecast period (2024-2031).Skin cancer, the most common cancer type, is primarily caused by solar and artificial ultraviolet (UV) radiation, responsible for about 90% of cases. UV radiation leads to mutations and disruptions in tumor suppressor genes, promoting skin malignancies. The Skin Cancer Market analysis provides a detailed outlook, covering market size, trends, and growth by treatment type and end user. It offers forecasts until 2029 for key regions, including the U.S., Europe, Brazil, China, and India.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/skin-cancer-market
Market Trends:
The rising diagnosis of skin cancer is expected to drive market growth. From 1994 to 2020, nonmelanoma skin cancer diagnoses in the U.S. increased by 77%, with sun exposure to UV radiation being a major risk factor. Approximately 9,500 people in the U.S. are diagnosed with skin cancer daily, with an estimated 196,060 new melanoma cases in 2021. Skin cancer is more common in non-Hispanic whites and is often diagnosed later in people of color, affecting areas less exposed to the sun. The increased diagnosis rates, especially among different demographics, are expected to boost market growth.
Segment Covered in the Skin Cancer Market:
By Treatment Type: Chemotherapy, Surgery, Non-Invasive Treatments, and Others
By End User: Hospital and Clinics, Cancer Research Institutes and Others
Regional Analysis:
The global skin cancer market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
The global skin cancer market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The skin cancer market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Major Key Players
• Amgen, Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• Sun Pharmaceutical Industries Ltd.
• Abbott Laboratories.
• Sanofi SA
• Novartis AG
• Qiagen NV
• Pfizer Inc.
Product Portfolio:
IMLYGIC (talimogene laherparepvec) is a prescription medication for treating melanoma that is either on the skin or in the lymph glands.
Related Reports
Stomach Cancer Treatment Market: https://www.datamintelligence.com/research-report/stomach-cancer-treatment-market
Ovarian Cancer Market: https://www.datamintelligence.com/research-report/ovarian-cancer-market
Mantle Cell Lymphoma Market: https://www.datamintelligence.com/research-report/mantle-cell-lymphoma-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/skin-cancer-market
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Skin Cancer Market Growing Rapidly Huge Growth by 2031- Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc. here
News-ID: 3649772 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Breast Implants Market 2025: Industry Developments, Future Growth, …
The Breast Implants Market is estimated at US$ 1.88 billion in 2024 and is anticipated to reach US$ 3.34 billion by 2033, expanding at a CAGR of 6.6% throughout the forecast period.
DataM Intelligence has published a new research report on "Breast Implants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.…
United States Bone Grafts and Substitutes Market 2025: Industry Developments, Fu …
The Bone Grafts and Substitutes Market grew from US$ 3.39 billion to US$ 3.60 billion in 2024 and is projected to reach US$ 6.37 billion by 2033, registering a CAGR of 6.6% during 2025-2033.
DataM Intelligence has published a new research report on "Bone Grafts and Substitutes Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top…
United States Biotechnology Market 2025: Industry Developments, Future Growth, S …
The Biotechnology Market size increased from US$ 1.53 trillion in 2023 to US$ 1.71 trillion in 2024 and is expected to reach US$ 5.08 trillion by 2033, growing at a CAGR of 13.1% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Biotechnology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of…
United States Bio-Betters Market 2025: Industry Developments, Future Growth, Sha …
The Bio-Betters Market size grew from US$ 49.87 billion in 2023 to US$ 53.73 billion in 2024 and is projected to reach US$ 110.46 billion by 2033, expanding at a CAGR of 8.5% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Biobetters Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
